Gastrointestinal Therapeutics Market

Gastrointestinal Therapeutics Market Size, Share & Trends Analysis
Report and Segment Forecast, 2025 | Grand View Research, Inc
“The global gastrointestinal therapeutics market size was valued at USD 51.9
billion in 2016 and is slated to expand at a lucrative CAGR of 6.6% over the
forecast period.”
The global Gastrointestinal Therapeutics Market size is expected to reach USD 65.1 billion by 2025, according
to a new report by Grand View Research, Inc., registering a 6.6% CAGR during the forecast period. Growing
geriatric population prone to gastrointestinal indications is one of the key factors anticipated to contribute to
market growth. According to a report by WHO, colon cancer caused nearly 694,000 deaths in 2014.
Growing geriatric population, especially in emerging economies, is expected to drive market growt h over the
coming years. Furthermore, initiatives undertaken by the Centers for Disease Control and Prevention (CDC) to
promote cancer screening nationwide is expected to boost market growth over the forecast period. The
Division of Cancer Prevention and Control (DCPC) supports National Colorectal Cancer Action Campaign
(NCCCP) and provides funds to aid research studies and implement strategies to control colorectal cancer. This
increase in initiatives for screening is expected to fuel sales of therapeutics and present lucrative growth
opportunities to the market.
To request a sample copy or view summary of this report, click the link below:
https://www.grandviewresearch.com/industry-analysis/gastrointestinal-therapeutics-market
Further key findings from the report suggest:

Based on product type, the branded drugs segment dominated in 2016 owing to high potency drugs
such as biologics and proton pump inhibitors. High growth of branded drugs over recent years is a result
Follow Us:
of positive patient outcomes and synergistic effect of various drugs used in conjunction in the treatment
regimen

Generics are expected to expand at a lucrative CAGR owing to their high cost-efficiency and rising
number of patent expirations

Ulcerative colitis accounted for the second-largest share in terms of application in 2016 owing to high
clinical urgency to curb growing prevalence of ulcerative colitis

The others segment, which includes constipation, nausea, and pancreatic insufficiency, accounted for
the largest share by application in 2016. This is a consequence of consistent efforts by government
organizations for promoting awareness and enhancing management of these conditions

The Crohn’s disease segment is expected to grow at a lucrative rate over the coming years due to
presence of extensive pipeline products in later stages of clinical trials

Retail pharmacy accounted for the largest share by way of distribution channel in 2016 owing to high
accessibility to retail stores and affordability. Online pharmacies are anticipated to witness lucrative
CAGR as they usually offer price discounts on bulk purchases.
Grand View Research has segmented the global gastrointestinal therapeutics market on the basis of type, route
of administration, application, distribution channel, and region:
Gastrointestinal Therapeutics Type Outlook (Revenue, USD Million, 2014 - 2025)

Branded
Follow Us:
o
Aminosalicylates
o
Antacids
o
Enzyme Replacement Therapies
o
Proton Pump Inhibitors
o
Laxatives
o
Antiemetics
o
H2 Antagonists
o
Antidiarrheals
o
Biologics
o
Others

Generics
Gastrointestinal Therapeutics Route of Administration Outlook (Revenue, USD Million, 2014 - 2025)

Oral

Intravenous

Others
Gastrointestinal Therapeutics Application Outlook (Revenue, USD Million, 2014 - 2025)

Ulcerative Colitis

Crohn’s Disease

GERD

Others
Gastrointestinal Therapeutics Distribution Channel Outlook (Revenue, USD Million, 2014 - 2025)

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies
Gastrointestinal Therapeutics Regional Outlook (Revenue, USD Million, 2014 - 2025)



North America
o
U.S.
o
Canada
Europe
o
U.K.
o
Germany
Asia Pacific
Follow Us:
o
Japan
o
China
o
India


Latin America
o
Brazil
o
Mexico
Middle East & Africa
o
Follow Us:
South Africa
Table of Content of Gastrointestinal Therapeutics Market
Chapter 1 Research Methodology & Scope
1.1 Region Wise Market Calculation
1.1.1 Region-wise market: Base estimates
1.1.2 Global market: CAGR calculation
1.2 Region-Based Segment Share Calculation
1.3 List of Secondary Sources
Chapter 2 Executive Summary
Chapter 3 Gastrointestinal Therapeutics Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.2 Market Driver Analysis
3.2.1 Increase in development of biologics
3.2.2 High prevalence of gastrointestinal diseases
3.3 Market Restraint Analysis
3.3.1 High number of patent expirations
3.4 Penetration & Growth Prospect Mapping
3.5 Gastrointestinal Therapeutics Market - SWOT Analysis, By Factor (Political & legal, economic, and
technological)
3.6 Industry Analysis - Porter’s
Chapter 4 Gastrointestinal Therapeutics Market: Type Estimates & Trend Analysis
4.1 Gastrointestinal Therapeutics Market: Type Movement Analysis
4.2 Branded
4.2.1 Branded market estimates and forecasts, 2014 - 2025 (USD Million)
4.2.2 Aminosalicylates
4.2.2.1 Aminosalicylates market estimates and forecasts, 2014 - 2025 (USD Million)
4.2.2.2 Antacids
4.2.2.2.1 Antacids market estimates and forecasts, 2014 - 2025 (USD Million)
4.2.2.3 Enzyme replacement therapies
4.2.2.3.1 Enzyme replacement therapies market estimates and forecasts, 2014 - 2025 (USD
Million)
4.2.2.4 Proton Pump Inhibitors
Follow Us:
4.2.2.4.1 Proton pump inhibitors market estimates and forecasts, 2014 - 2025 (USD Million)
4.2.2.5 Laxatives
4.2.2.5.1 Laxatives market estimates and forecasts, 2014 - 2025 (USD Million)
4.2.2.6 Anti-emetics
4.2.2.6.1 Anti-emetics market estimates and forecasts, 2014 - 2025 (USD Million)
4.2.2.7 H2 antagonists
4.2.2.7.1 H2 antagonists market estimates and forecasts, 2014 - 2025 (USD Million)
4.2.2.8 Antidiarrheals
4.2.2.8.1 Antidiarrheals market estimates and forecasts, 2014 - 2025 (USD Million)
4.2.2.9 Biologics
4.2.2.9.1 Biologics market estimates and forecasts, 2014 - 2025 (USD Million)
4.2.2.10 Others
4.2.2.10.1 Others market estimates and forecasts, 2014 - 2025 (USD Million)
4.2.3 Generics
4.2.3.1 Generics market estimates and forecasts, 2014 - 2025 (USD Million)
Chapter 5 Gastrointestinal Therapeutics Market: Route of Administration Estimates & Trend Analysis
5.1 Gastrointestinal Therapeutics Market: Route of Administration Movement Analysis
5.2 Oral
5.2.1 Oral market estimates and forecasts, 2014 - 2025 (USD Million)
5.3 Intravenous
5.3.1 Intravenous market estimates and forecasts, 2014 - 2025 (USD Million)
5.4 Others
5.4.1 Others market estimates and forecasts, 2014 - 2025 (USD Million)
Chapter 6 Gastrointestinal Therapeutics Market: Application Estimates & Trend Analysis
6.1 Gastrointestinal Therapeutics Market: Application Movement Analysis
6.2 Ulcerative Colitis
6.2.1 Ulcerative Colitis market estimates and forecasts, 2014 - 2025 (USD Million)
6.3 Crohn’s Disease
6.3.1 Crohn’s disease market estimates and forecasts, 2014 - 2025 (USD Million)
6.4 Gastroesophageal Reflux (GERD)
6.4.1 GERD market estimates and forecasts, 2014 - 2025 (USD Million)
Follow Us:
6.5 Others
6.5.1 Others market estimates and forecasts, 2014 - 2025 (USD Million)
Chapter 7 Gastrointestinal Therapeutics Market: Distribution Channel Estimates & Trend Analysis
7.1 Gastrointestinal Therapeutics Market: Distribution Channel Movement Analysis
7.2 Hospital Pharmacies
7.2.1 Hospital pharmacies market estimates and forecasts, 2014 - 2025 (USD Million)
7.3 Retail Pharmacies
7.3.1 Retail pharmacies market estimates and forecasts, 2014 - 2025 (USD Million)
7.4 Online Pharmacies
7.4.1 Online pharmacies market estimates and forecasts, 2014 - 2025 (USD Million)
Chapter 8 Gastrointestinal Therapeutics Market: Regional Estimates & Trend Analysis, by Type, Route of
Administration, Application, Distribution Channel
8.1 Gastrointestinal therapeutics market shares by region, 2016 & 2025
8.2 North America
8.2.1 North America gastrointestinal therapeutics market estimates and forecasts, 2014 - 2025 (USD
Million)
8.2.2 U.S.
8.2.2.1 U.S. gastrointestinal therapeutics market estimates and forecasts, 2014 - 2025(USD Million)
8.2.3 Canada
8.2.3.1 Canada gastrointestinal therapeutics market estimates and forecasts, 2014 - 2025(USD
Million)
8.3 Europe
8.3.1 Europe gastrointestinal therapeutics market estimates and forecasts, 2014 - 2025 (USD Million)
8.3.2 Germany
8.3.2.1 Germany gastrointestinal therapeutics market estimates and forecasts, 2014 - 2025 (USD
Million)
8.3.3 U.K.
8.3.3.1 U.K. gastrointestinal therapeutics market estimates and forecasts, 2014 - 2025(USD Million)
8.4 Asia Pacific
8.4.1 Asia Pacific gastrointestinal therapeutics market estimates and forecasts, 2014 - 2025 (USD
Million)
Follow Us:
8.4.2 Japan
8.4.2.1 Japan gastrointestinal therapeutics market estimates and forecasts, 2014 - 2025 (USD
Million)
8.4.3 China
8.4.3.1 China gastrointestinal therapeutics market estimates and forecasts, 2014 - 2025 (USD
Million)
8.4.4 India
8.4.4.1 India gastrointestinal therapeutics market estimates and forecasts, 2014 - 2025 (USD Million)
8.5 Latin America
8.5.1 Latin America gastrointestinal therapeutics market estimates and forecasts, 2014 - 2025 (USD
Million)
8.5.2 Brazil
8.5.2.1 Brazil gastrointestinal therapeutics market estimates and forecasts, 2014 - 2025 (USD Million)
8.5.3 Mexico
8.5.3.1 Mexico gastrointestinal therapeutics market estimates and forecasts, 2014 - 2025 (USD
Million)
8.6 MEA
8.6.1 MEA gastrointestinal therapeutics market estimates and forecasts, 2014 - 2025 (USD Million)
8.6.2 South Africa
8.6.2.1 South Africa gastrointestinal therapeutics market estimates and forecasts, 2014 - 2025 (USD
Million)
Chapter 9 Competitive Landscape
9.1 Market participation categorization
9.2 List of Market Players
9.3 Company Profiles
9.3.1 Abbott Laboratories
9.3.1.1 Company overview
9.3.1.2 Financial performance
9.3.1.3 Product benchmarking
9.3.2 Allergan plc
9.3.2.1 Company overview
Follow Us:
9.3.2.2 Financial performance
9.3.2.3 Product benchmarking
9.3.2.4 Strategic initiatives
9.3.3 AstraZeneca
9.3.3.1 Company overview
9.3.3.2 Financial performance
9.3.3.3 Product benchmarking
9.3.4 Bayer AG
9.3.4.1 Company overview
9.3.4.2 Financial performance
9.3.4.3 Product benchmarking
9.3.5 GlaxoSmithKline plc
9.3.5.1 Company overview
9.3.5.2 Financial performance
9.3.5.3 Product benchmarking
9.3.6 Janssen Pharmaceuticals
9.3.6.1 Company overview
9.3.6.2 Financial performance
9.3.6.3 Product benchmarking
9.3.6.4 Strategic initiatives
9.3.7 Takeda Pharmaceuticals
9.3.7.1 Company overview
9.3.7.2 Financial performance
9.3.7.3 Product benchmarking
9.3.7.4 Strategic initiatives
9.3.8 Valeant Pharmaceuticals
9.3.8.1 Company overview
9.3.8.2 Financial performance
9.3.8.3 Product benchmarking
9.3.8.4 Strategic initiatives
9.3.9 Pfizer
Follow Us:
9.3.9.1 Company overview
9.3.9.2 Financial performance
9.3.9.3 Product benchmarking
9.3.10 AbbVie, Inc.
9.3.10.1 Company overview
9.3.10.2 Financial performance
9.3.10.3 Product benchmarking
Follow Us:
About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated research reports, customized
research reports, and consulting services. To help clients make informed business decisions, the company offers
market intelligence studies ensuring relevant and fact-based research across a range of industries including
technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: [email protected]
For More Information: https://www.grandviewresearch.com
Blog: https://healthcareforecastreport.blogspot.com/
Follow Us:

The global gastrointestinal therapeutics market size was valued at USD 51.9 billion in 2016 and is slated to expand at a lucrative CAGR of 6.6% over the forecast period

Download Report